Hacker News

points by EA-3167 2 days ago | 0 comments

Exactly. The reality is that spitting out drug candidates is already the “easy” part… the harder part is getting that candidate through clinical trials, which is where 90% of such journeys end.

As always Anthropic is saying literally anything if it gets them closer to the giant bucket of money that is the IPO.

[–] johntb86 2 days ago

If the candidates were better, then <90% would end their journeys at the clinical trials. Though that's not to say that they've provided any real evidence that their candidates actually are better yet

[–] w4der 2 days ago

Many times issues with clinical trials is not a technical one, it's a human one, practitioners unwilling to test, patients that stop showing up, red tape, committees, denial of consent, etc. I do not see how AI as it stands currently can solve those issues.

[–] azan_ 2 days ago

So getting drug candidates with high success rate actually is the hard part.